NO811721L - R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape - Google Patents
R. farmasoeytisk preparat med forbedrede frigjoeringsegenskapeInfo
- Publication number
- NO811721L NO811721L NO811721A NO811721A NO811721L NO 811721 L NO811721 L NO 811721L NO 811721 A NO811721 A NO 811721A NO 811721 A NO811721 A NO 811721A NO 811721 L NO811721 L NO 811721L
- Authority
- NO
- Norway
- Prior art keywords
- coating
- pharmaceutical preparation
- release property
- improved release
- active substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8003805A SE8003805L (sv) | 1980-05-21 | 1980-05-21 | En farmaceutisk beredning med forbettrade utlosningsegenskap |
Publications (1)
Publication Number | Publication Date |
---|---|
NO811721L true NO811721L (no) | 1981-11-23 |
Family
ID=20341009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO811721A NO811721L (no) | 1980-05-21 | 1981-05-20 | R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0040590A3 (el) |
DK (1) | DK221281A (el) |
ES (1) | ES8301630A1 (el) |
GR (1) | GR75634B (el) |
NO (1) | NO811721L (el) |
PH (1) | PH16539A (el) |
PT (1) | PT73065B (el) |
SE (1) | SE8003805L (el) |
ZA (1) | ZA813017B (el) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57500432A (el) * | 1980-03-20 | 1982-03-11 | ||
US4960765A (en) * | 1980-03-20 | 1990-10-02 | Farmaceutisk Laboratorium Ferring A/S | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
ZA825384B (en) * | 1981-07-31 | 1983-05-25 | Tillott J B Ltd | Orally administrable pharmaceutical compositions |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
DE3151196A1 (de) * | 1981-12-23 | 1983-06-30 | Kurt Heinz Prof. Dr. 7800 Freiburg Bauer | Verfahren zur herstellung von gut loeslichen 5-aminosalicylsaeure-arzneimittelzubereitungen |
US4994260A (en) * | 1982-05-28 | 1991-02-19 | Astra Lakemedel Aktiebolag | Pharmaceutical mixture |
SE8203953D0 (sv) * | 1982-06-24 | 1982-06-24 | Astra Laekemedel Ab | Pharmaceutical mixture |
FR2554718B1 (fr) * | 1983-11-14 | 1986-04-04 | Ethypharm Sa | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
FR2556964A1 (fr) * | 1983-12-23 | 1985-06-28 | Ile De France | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
IL77186A0 (en) * | 1985-11-29 | 1986-04-29 | Touitou Elka | Pharmaceutical insulin composition |
US4861598A (en) * | 1986-07-18 | 1989-08-29 | Euroceltique, S.A. | Controlled release bases for pharmaceuticals |
US4814354A (en) * | 1986-09-26 | 1989-03-21 | Warner-Lambert Company | Lipid regulating agents |
SE460946B (sv) * | 1987-03-16 | 1989-12-11 | Lejus Medical Ab | En multipel-unit-dos komposition av kinidinglukonat |
US5472710A (en) * | 1988-04-16 | 1995-12-05 | Schwarz Pharma Ag | Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture |
DE3812799A1 (de) * | 1988-04-16 | 1989-10-26 | Sanol Arznei Schwarz Gmbh | Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung |
IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
DE69020758T2 (de) * | 1989-03-10 | 1995-12-07 | Yamanouchi Pharma Co Ltd | Die Wirkstoffabgabe steuerndes Überzugsmaterial für lang wirksame Formulierungen. |
US5372823A (en) * | 1989-03-16 | 1994-12-13 | Bristol-Myers Squibb Company | Direct compression cholestyramine tablet and solvent-free coating thereof |
PT93637A (pt) * | 1989-04-20 | 1990-11-20 | Procter & Gamble | Metodo para o tratamento de desordens funcionais intestinais/colonicas, especialmente o sindrome de irritacao intestinal |
US5643602A (en) * | 1989-11-22 | 1997-07-01 | Astra Aktiebolag | Oral composition for the treatment of inflammatory bowel disease |
SE8903914D0 (sv) | 1989-11-22 | 1989-11-22 | Draco Ab | Oral composition for the treatment of inflammatory bowel diseases |
GB9015822D0 (en) * | 1990-07-18 | 1990-09-05 | Beecham Group Plc | Compositions |
GB2253346A (en) * | 1991-02-22 | 1992-09-09 | John Rhodes | Delayed release oral dosage forms for treatment of intestinal disorders |
AU1587392A (en) * | 1991-03-15 | 1992-10-21 | Norwich Eaton Pharmaceuticals, Inc. | The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d) |
US5914132A (en) * | 1993-02-26 | 1999-06-22 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
DE29502547U1 (de) * | 1995-02-16 | 1995-03-30 | Röhm GmbH, 64293 Darmstadt | Thermoplastisches Überzugs- und Bindemittel für Arzneiformen |
DE19732903A1 (de) | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
EP1053752A1 (en) | 1998-02-10 | 2000-11-22 | Yoshitomi Pharmaceutical Industries, Ltd. | Preparations with controlled release |
NZ513037A (en) | 1999-01-29 | 2003-05-30 | Disphar Internat B | Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract |
IT1318376B1 (it) * | 2000-03-07 | 2003-08-25 | Pharmatec Internat S R L | Forme solide orali a rilascio controllato contenenti mesalazina comeprincipio attivo. |
CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
AU2003269741A1 (en) * | 2002-05-15 | 2003-12-02 | Sun Pharmaceutical Industries Limited | Coated sustained release tablets of a hygroscopic compound for once-a-day therapy |
PA8578501A1 (es) | 2002-07-25 | 2005-02-04 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
GB2430368B (en) | 2004-03-30 | 2009-08-26 | Ilypsa Inc | Methods and compositions for treatment of ion imbalances |
US8282960B2 (en) * | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
CA2576386A1 (en) * | 2004-08-13 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
US8889184B2 (en) * | 2006-09-07 | 2014-11-18 | Losan Pharma Gmbh | Particulate form of a pharmaceutical composition which is easy to swallow |
JP2011509266A (ja) * | 2008-01-10 | 2011-03-24 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 活性物質の制御放出が促進された、コーティングされた医薬製剤もしくはニュートラシューティカル製剤 |
TR201902212T4 (tr) * | 2008-01-10 | 2019-06-21 | Evonik Roehm Gmbh | Geli̇şmi̇ş deği̇şken dozlu akti̇f madde salimina sahi̇p kapli farmasöti̇k veya nutrasöti̇k preparat |
NZ592049A (en) | 2008-10-03 | 2012-11-30 | Falk Pharma Gmbh | Compositions and methods for the treatment of bowel diseases with granulated mesalamine |
CA3018328A1 (en) | 2014-10-31 | 2016-04-30 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
EP4057998A1 (fr) | 2019-11-13 | 2022-09-21 | Ethypharm | Procédé de fabrication d'une composition pharmaceutique à administration orale et à délivrance colonique |
FR3102931B1 (fr) | 2019-11-13 | 2021-12-24 | Ethypharm Sa | Procédé de fabrication d’une composition pharmaceutique à administration orale et à délivrance colonique |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1204363B (de) * | 1963-09-10 | 1965-11-04 | Hoffmann La Roche | Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt |
GB1297719A (el) * | 1970-06-11 | 1972-11-29 | ||
DE2340060A1 (de) * | 1973-08-08 | 1975-02-20 | Scherer Gmbh R P | Magensaftresistente gelatinekapseln und verfahren zu deren herstellung |
-
1980
- 1980-05-21 SE SE8003805A patent/SE8003805L/ not_active Application Discontinuation
-
1981
- 1981-05-06 ZA ZA00813017A patent/ZA813017B/xx unknown
- 1981-05-19 PH PH25653A patent/PH16539A/en unknown
- 1981-05-19 EP EP81850087A patent/EP0040590A3/en not_active Withdrawn
- 1981-05-20 PT PT73065A patent/PT73065B/pt unknown
- 1981-05-20 NO NO811721A patent/NO811721L/no unknown
- 1981-05-20 GR GR64998A patent/GR75634B/el unknown
- 1981-05-20 ES ES81502345A patent/ES8301630A1/es not_active Expired
- 1981-05-20 DK DK221281A patent/DK221281A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT73065A (en) | 1981-06-01 |
PT73065B (en) | 1983-02-08 |
GR75634B (el) | 1984-08-01 |
EP0040590A2 (en) | 1981-11-25 |
ZA813017B (en) | 1982-05-26 |
ES502345A0 (es) | 1982-12-16 |
PH16539A (en) | 1983-11-10 |
ES8301630A1 (es) | 1982-12-16 |
DK221281A (da) | 1981-11-22 |
SE8003805L (sv) | 1981-11-22 |
EP0040590A3 (en) | 1983-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO811721L (no) | R. farmasoeytisk preparat med forbedrede frigjoeringsegenskape | |
DE69622510D1 (de) | Nifedipinzubereitung mit langanhaltender Freisetzung | |
DE3855852D1 (de) | Kugelförmige Granula mit Kern sowie deren Herstellung | |
DK400685A (da) | Praeparat med kontrolleret afgivelse | |
ES2001897A6 (es) | Procedimiento para la fabricacion de una tableta de liberacion controlada | |
MY101593A (en) | Sustained release preparation. | |
TR199800121T1 (xx) | Uzat�lm�� etki s�resine sahip ipratropyumbromid'in bir enantiyomeri. | |
ATE286724T1 (de) | Überzogene arzneiformen mit kontrollierter wirkstoffabgabe | |
OA07628A (fr) | Résinate d'un acide carboxylique substitué, procédés pour sa préparation, son utilisation et compositions pharmaceutiques le contenant. | |
KR860000865A (ko) | 약제 제형의 제조방법 | |
DK1169032T3 (da) | Ketoprofen-mikrogranuler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater | |
PT71495A (fr) | Procede d'obtention d'extraits de lierre grimpant et de compositions pharmaceutiques qui en contiennent | |
FR2453648A1 (fr) | Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique | |
BE883943A (fr) | Derives de l'enkaphaline, leur preparation et leurs utilisations therapeutiques, notamment comme analgesiques | |
FR2372825A1 (fr) | Derives du bezimidazole et leur utilisation therapeutique comme hypotenseurs | |
PT72397B (en) | Process for the preparation of n,n-dialkyl-o-(pyrazol-5-yl) carbanic acid derivatives and insecticide and nematicide compositions thereof | |
JPS649205A (en) | Fixer composition, organic polymer for fixer, coating supporter and manufacture | |
ES8600282A1 (es) | Procedimiento para la obtencion de 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro)1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol | |
NZ189212A (en) | 3-amino substituted 1,5-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions | |
TW289733B (en) | Process for preparing round pellets of Omeprazole for oral administration | |
JPS5748908A (en) | Prolonged release type nicomol pharmaceutical | |
JPS6422824A (en) | Antifungal agent | |
ES457496A1 (es) | Procedimiento para la obtencion de una composicion pulveru- lenta e hidrosoluble de sulfamidina y pirimetamina. | |
JPS5231119A (en) | Imitated animal hairlike synthetic fibers | |
PH14155A (en) | Pharmaceutical compositions containing racemic or optically active 1-(2',6'-dimethyl-phenoxy)-2-methylaminopropane and method of use |